![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology. | ||
Founding Date | Founding Date 1996 | Founding Date 1890 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Bedford, US HQ Bedford, US Bedford, US | |
Employees | Employees 75,883 | Employees 3,744 | Employees 16740% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.1 b | Valuation ($) 1.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $52m (FY, 2025) |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $6.6m (FY, 2025) |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $45.4m (FY, 2025) |
Net income | Net income $14b (FY, 2025) | Net income N/A | Net income ($265.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 74.4m | Total funding raised $ 73.3m |
Santen is a specialized pharmaceutical company focusing on ophthalmology.
View company
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
View company